Anti-nociceptive effect of Faecalibacterium prausnitzii in non-inflammatory IBS-like models

Citations Over TimeTop 10% of 2016 papers

Abstract

Visceral pain and intestinal dysbiosis are associated with Irritable Bowel Syndrome (IBS), a common functional gastrointestinal disorder without available efficient therapies. In this study, a decrease of Faecalibacterium prausnitzii presence has been observed in an IBS-like rodent model induced by a neonatal maternal separation (NMS) stress. Moreover, it was investigated whether F. prausnitzii may have an impact on colonic sensitivity. The A2-165 reference strain, but not its supernatant, significantly decreased colonic hypersensitivity induced by either NMS in mice or partial restraint stress in rats. This effect was associated with a reinforcement of intestinal epithelial barrier. Thus, F. prausnitzii exhibits anti-nociceptive properties, indicating its potential to treat abdominal pain in IBS patients.

Related Papers

• → A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis(2013)1,868 cited
• → The Commensal Bacterium Faecalibacterium prausnitzii Is Protective in DNBS-induced Chronic Moderate and Severe Colitis Models(2014)283 cited
• → F. prausnitzii and its supernatant increase SCFAs-producing bacteria to restore gut dysbiosis in TNBS-induced colitis(2021)86 cited
• → Progress with treating the microbial dysbiosis associated with irritable bowel syndrome(2016)1 cited
• → F. prausnitzii and Its Supernatant Increase SCFAs-producing Bacteria to Restore Gut Dysbiosis in TNBS-Induced Colitis(2020)1 cited